Clinical Predictors Associated With Proton Pump Inhibitor-Induced Hypomagnesemia

被引:0
作者
Kim, Sunyong [1 ]
Lee, Hyuk [1 ]
Park, Chan Hyuk [1 ]
Shim, Choong Nam [1 ]
Lee, Hyun Jik [1 ]
Park, Jun Chul [1 ]
Shin, Sung Kwan [1 ]
Lee, Sang Kil [1 ]
Lee, Yong Chan [1 ]
Kim, Ha Yan [2 ]
Kang, Dae Ryong [2 ]
机构
[1] Yonsei Univ, Inst Gastroenterol, Dept Internal Med, Coll Med, Seoul 120752, South Korea
[2] Yonsei Univ, Coll Med, Biostat Collaborat Unit, Seoul 120752, South Korea
关键词
proton pump inhibitor; magnesium; hypomagnesemia; risk factor; ESOMEPRAZOLE; OMEPRAZOLE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There is increasing evidence and case reports regarding proton pump inhibitor (PPI)-induced hypomagnesemia. Our study aimed to clarify the relationship between PPI use and serum magnesium levels and to specify high-risk patients. We retrospectively studied 112 consecutive patients aged 20 years or older who were treated with PPI for >= 30 days and whose serum magnesium levels were available for the PPI treatment period. We compared the mean level of serum magnesium of the enrolled patients with PPI treatment with matched controls. There were no significant differences between the matched PPI users (n = 105) and nonusers (n = 210) in the magnesium levels (0.85 +/- 0.09 vs. 0.86 +/- 0.16 mM, P = 0.297). In a subgroup analysis of a PPI user group, hypomagnesemia could be observed in 32 patients but not in 80 patients. In multivariate analyses, PPI use for >1 year, age less than 45 years, and concurrent cisplatin or carboplatin use were significantly associated with PPI-induced hypomagnesemia {P = 0.042, odds ratio [OR; 95% confidence interval (CI)]: 5.388 [1.056-27.493]; P = 0.007, OR [95% CI]: 4.710 [1.523-14.571]; P = 0.007, OR [95% CI]: 13.404 [2.066-86.952], respectively} after adjusting for confounders. This study shows that long-term PPI use is associated with hypomagnesemia in hospitalized adult patients. Therefore, serum magnesium levels should be checked before the initiation of PPI treatment and during the treatment period in patients, particularly those concurrently using platinum-based chemotherapy or who are expected to use PPI for long periods.
引用
收藏
页码:14 / 21
页数:8
相关论文
共 27 条
[1]   Gastric Acid Suppression by Proton Pump Inhibitors as a Risk Factor for Clostridium difficile-Associated Diarrhea in Hospitalized Patients [J].
Aseeri, Mohammed ;
Schroeder, Todd ;
Kramer, Joan ;
Zackula, Rosalee .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (09) :2308-2313
[2]   Hypomagnesemia Induced by Several Proton-Pump Inhibitors [J].
Broeren, Maarten A. C. ;
Geerdink, Engelien A. M. ;
Vader, Huib L. ;
Bake, A. Warmold L. van den Wall .
ANNALS OF INTERNAL MEDICINE, 2009, 151 (10) :755-756
[3]   Recent Safety Concerns With Proton Pump Inhibitors [J].
Chen, Joan ;
Yuan, Yuhong Cathy ;
Leontiadis, Grigorios I. ;
Howden, Colin W. .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2012, 46 (02) :93-114
[4]   Severe hypomagnesaemia in long-term users of proton-pump inhibitors [J].
Cundy, T. ;
Dissanayake, A. .
CLINICAL ENDOCRINOLOGY, 2008, 69 (02) :338-341
[5]   Proton pump inhibitors and severe hypomagnesaemia [J].
Cundy, Tim ;
Mackay, Jonathan .
CURRENT OPINION IN GASTROENTEROLOGY, 2011, 27 (02) :180-185
[6]   Proton-pump inhibitors and hypomagnesemic hypoparathyroidism [J].
Epstein, Martin ;
McGrath, Shaun ;
Law, Florence .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (17) :1834-1836
[7]   Chronic use of proton-pump inhibitors associated with giardiasis: A rare cause of hypomagnesemic hypoparathyroidism? [J].
Francois, A. ;
Levy-Bohbot, N. ;
Caron, J. ;
Durlach, V. .
ANNALES D ENDOCRINOLOGIE, 2008, 69 (05) :446-448
[8]   Uses of proton pump inhibitors and hypomagnesemia [J].
Gau, Jen-Tzer ;
Yang, Yu-Xiao ;
Chen, Roger ;
Kao, Tzu-Cheg .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (05) :553-559
[9]   Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs [J].
Hawkey, CJ ;
Karrasch, JA ;
Szczepanski, L ;
Walker, DG ;
Barkun, A ;
Swannell, AJ ;
Yeomans, ND .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (11) :727-734
[10]   Systematic review: hypomagnesaemia induced by proton pump inhibition [J].
Hess, M. W. ;
Hoenderop, J. G. J. ;
Bindels, R. J. M. ;
Drenth, J. P. H. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (05) :405-413